At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Platinum complexes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Nov 2000 No-Development-Reported for Cancer in South Korea (Unknown route)
- 20 Jul 1998 Profile reviewed
- 22 May 1995 Phase-I clinical trials for Cancer in South Korea (Unknown route)